1-4 of 4
Josep-Maria Marti, MD
Close
Sort by
Journal Articles

Methylation Patterns in Patients with High-Risk Myelodysplatic Syndromes and Secondary Acute Myeloid Leukemia Treated with Azacitidine (high-risk MDS 2009 protocol from CETLAM Group)

Marta Cabezón, Yulia Medvedeva, PhD, Joan Bargay, MD PhD, Blanca Xicoy, MD PhD, Sílvia Marcé, PhD, Ramon Guàrdia, MD PhD, Salut Brunet, MD PhD, Carmen Pedro, MD PhD, Mar Tormo, MD PhD, Victor Marco, Lourdes Escoda, MD PhD, Llorenç Font, MD PhD, Elena Rámila, MD PhD, David Valcárcel, MD PhD, Josep Maria Martí, MD PhD, Josep Borras, Evarist Feliu, MD PhD, Fuensanta Millá, MD PhD, Tanya Vavouri, PhD, Lurdes Zamora, PhD
Journal: Blood
Blood (2015) 126 (23): 1682.
https://doi.org/10.1182/blood.V126.23.1682.1682
Published: 2015
Journal Articles

Mutational Studies Using Next Generation Sequencing in High Risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia Patients Treated with Azacitidine (High risk MDS 2009 protocol from CETLAM Group)

Marta Cabezon, Joan Bargay, MD PhD, Blanca Xicoy, MD PhD, Laura Palomo, MSc, Sílvia Marcé, PhD, Ramón Guàrdia, MD PhD, Salut Brunet, MD PhD, Carmen Pedro, MD PhD, Mar Tormo, MD PhD, Vera Ademà, MSc, Victor Marco, Lourdes Escoda, MD PhD, Llorenç Font, MD PhD, Elena Rámila, MD PhD, Josep Maria Martí, MD PhD, David Valcarcel, MD PhD, Josep Borras, Evarist Feliu, MD PhD, Fuensanta Millá, MD PhD, Lurdes Zamora, PhD
Journal: Blood
Blood (2015) 126 (23): 2905.
https://doi.org/10.1182/blood.V126.23.2905.2905
Published: 2015
Journal Articles

Central Nervous System (CNS) Relapse in Adult Patients with Acute Lymphoblastic Leukemia (ALL): Frequency and Prognosis in 467 Patients without Cranial Irradiation for CNS Prophylaxis.

Juan-Manuel Sancho, MD, Josep-Maria Ribera, PhD, Albert Oriol, MD, Jesus-Maria Hernandez-Rivas, PhD, Concepcion Rivas, MD, Concepcion Bethencourt, MD, Javier Fernández-Calvo, MD, Ricardo Parody, MD, Guillermo Deben, MD, Jose-Luis Bello, MD, Josep-Maria Marti, MD, Eugenia Abella, PhD, Eloy Del-Potro, MD, Maria-Jose Terol, MD, Evarist Feliu, PhD
Journal: Blood
Blood (2005) 106 (11): 1841.
https://doi.org/10.1182/blood.V106.11.1841.1841
Published: 2005
Journal Articles

Germline Polymorphisms Provide Strong Prognostic Information in Intermediate Risk Acute Myeloblastic Leukemia (AML).

Alvaro Urbano-Ispizua, MD, Salut Brunet, MD, Mariano Monzo, MD, PhD, Granada Perea, MD, Alfons Navarro, PhD, Jordi Esteve, MD, Juan Berlanga, MD, Josep-Maria Ribera, MD, Javier Bueno, MD, Andreu Llorente, MD, Juan Besalduch, MD, Ramon Guardia, MD, Mar Tormo, MD, Carmen Pedro, MD, Juan-Maria Sanchez, MD, Pio Torres, MD, Maria-Paz Queipo de Llano, MD, Llorens Font, MD, Jose-Maria Moraleda, MD, Josep-Maria Marti, MD, Pilar Vivancos, MD, Maria-Jesus Peñarubia, MD, Josep Nomdedeu, MD, Emili Montserrat, MD, Jorge Sierra, MD
Journal: Blood
Blood (2004) 104 (11): 398.
https://doi.org/10.1182/blood.V104.11.398.398
Published: 2004